FDA Drug Recalls

Recalls / Class II

Class IID-0018-2021

Product

Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-952-30

Affected lot / code info
Lot: 27AU1801 Exp. 02/28/2021

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer

Recalling firm

Firm
Direct Rx
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
94 Worldwide Dr, N/A, Dawsonville, Georgia 30534-6828

Distribution

Quantity
33 bottles
Distribution pattern
GA

Timeline

Recall initiated
2019-04-30
FDA classified
2020-10-05
Posted by FDA
2020-10-14
Terminated
2020-12-04
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0018-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls